Literature DB >> 8207417

Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives.

H Ni1, N J Burns, G J Chang, M J Zhang, M R Wills, D W Trent, P G Sanders, A D Barrett.   

Abstract

Nucleotide sequences of the 5' non-coding region and the structural protein genes of the live, attenuated Japanese encephalitis vaccine virus strains SA14-2-8 and SA14-5-3 and the wild-type parental strain SA14/USA were determined. SA14-2-8 differed from SA14/USA by 13 nucleotides and eight amino acids whereas SA14-5-3 differed from SA14/USA by 15 nucleotides and eight amino acids. A comparison of the 5' non-coding region and amino acid sequences of the structural proteins of these two attenuated vaccine strains and of vaccine strains SA14-14-2/PHK and SA14-14-2/PDK with three sequences of their wild-type parent SA14 virus was performed. This revealed only two common amino acid substitutions at positions 138 and 176 in the envelope (E) protein. The substitution at E138 was predicted to cause a change in the secondary structure of the E protein. These two amino acid substitutions in the E protein may contribute to attenuation of the Japanese encephalitis vaccine viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207417     DOI: 10.1099/0022-1317-75-6-1505

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants.

Authors:  Jaclyn A Kaiser; Huanle Luo; Steven G Widen; Thomas G Wood; Claire Y-H Huang; Tian Wang; Alan D T Barrett
Journal:  Vaccine       Date:  2019-10-11       Impact factor: 3.641

2.  Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Authors:  T P Monath; I Levenbook; K Soike; Z X Zhang; M Ratterree; K Draper; A D Barrett; R Nichols; R Weltzin; J Arroyo; F Guirakhoo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; José Bustos-Arriaga; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

4.  Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; Stephen S Whitehead
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.

Authors:  Thomas P Monath; Juan Arroyo; Inessa Levenbook; Zhen-Xi Zhang; John Catalan; Ken Draper; Farshad Guirakhoo
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

Authors:  J Arroyo; F Guirakhoo; S Fenner; Z X Zhang; T P Monath; T J Chambers
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 7.  Recent advances in Japanese encephalitis.

Authors:  Tom Solomon
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Acidity/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice.

Authors:  Xuchen Zheng; Hao Zheng; Wu Tong; Guoxin Li; Tao Wang; Liwei Li; Fei Gao; Tongling Shan; Hai Yu; Yanjun Zhou; Yafeng Qiu; Zhiyong Ma; Guangzhi Tong
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

9.  Sultam thiourea inhibition of West Nile virus.

Authors:  Eric Barklis; Amelia Still; Mohammad I Sabri; Alec J Hirsch; Janko Nikolich-Zugich; James Brien; Tenzin Choesang Dhenub; Isabel Scholz; Ayna Alfadhli
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

10.  Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors:  Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.